Hudson Bay Capital Management Buys Stake in Chemours

Got story updates? Submit your updates here. ›

Hudson Bay Capital Management LP acquired a new stake of 121,537 shares in The Chemours Company (NYSE:CC) during the third quarter of 2025, according to a recent SEC filing. The shares were valued at approximately $1.925 million, representing about 0.08% ownership in Chemours at the end of the reporting period.

Why it matters

The Chemours Company is a major specialty chemicals producer, and this investment by Hudson Bay Capital Management, a prominent hedge fund, suggests they see potential upside in the company's stock. Chemours has faced some challenges in recent years, but this new investment could signal a turnaround is underway.

The details

Hudson Bay Capital Management, a New York-based hedge fund, disclosed the new stake in Chemours in a 13F filing with the SEC. The firm acquired 121,537 shares of the specialty chemicals company during the third quarter of 2025. Chemours produces a variety of products including fluoroproducts, titanium technologies, and chemical solutions.

• Hudson Bay Capital Management acquired the Chemours shares in Q3 2025.